7-chlorokynurenic acid has been researched along with Experimental High Pressure Neurological Syndrome in 1 studies
7-chlorokynurenic acid: selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex; structure given in first source
7-chlorokynurenic acid : A quinolinemonocarboxylic acid that is quinaldic acid which is substituted by a hydroxy group at position 4 and by a chlorine at position 7. It is a potent NMDA glutamate receptor antagonist which antagonizes the strychnine-insensitive glycine site of the NMDA receptor. It also prevents neurodegeneration produced by quinolinic acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "4." | 1.29 | Possible NMDA antagonist properties of drugs that affect high pressure neurological syndrome. ( Bowser-Riley, F; Davies, SN; Shuker, MA, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shuker, MA | 1 |
| Bowser-Riley, F | 1 |
| Davies, SN | 1 |
1 other study available for 7-chlorokynurenic acid and Experimental High Pressure Neurological Syndrome
| Article | Year |
|---|---|
Possible NMDA antagonist properties of drugs that affect high pressure neurological syndrome.
Topics: 2-Amino-5-phosphonovalerate; Action Potentials; Alkaloids; Animals; Benzimidazoles; High Pressure Ne | 1994 |